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Background and Purpose: The guidelines set forth by the American Physical Therapy 
Association (APTA) contraindicate exercise when hemoglobin blood values are <8 g/dL, 
platelets are <20,000/mL, or white blood cells (WBCs) are <5,000/mm
3
 accompanied by 
a fever. The purpose of this study was to determine if APTA hematological guidelines are 
appropriate for determining activity levels in children undergoing chemotherapy.  The 
guidelines were initially established for patients with acute changes in blood values, but it 
has been questioned if these guidelines are appropriate for populations with chronically 
low blood values such as children with cancer.   
Methods: A retrospective chart review was done using a consecutive sample of children 
with cancer being seen for physical therapy (PT) while undergoing chemotherapy.  A 
maximum of four PT sessions per child were included for a total of 201 chart reviews. 
Subject’s hemoglobin, platelet, and WBC values were recorded within 24 hours of a PT 
session. Interventions and modifications to PT treatment were documented. The patient’s 
chart was reviewed for two days following the PT visit and any critical incidences as 
defined by the researchers were recorded.  
Results: Participants included 33 males and 40 females ranging in age from 3 to 18, with 
a mean age of 9.5 years.  The most common cancer diagnoses were acute lymphoblastic 
leukemia, Wilms’ tumor, and osteosarcoma.  A Fisher’s exact test showed no significant 
relationship between low hemoglobin, low platelets, or low WBCs and number of critical 
incidences (2.56, p = 0.196; 0.198, p = 0.776; 0.501, p = 0.444 respectively).  A risk ratio 





found to be 4.3 (CI 0.58 – 32.30) for low hemoglobin, 0.79 (CI 0.29 – 2.20) for low 
platelets, and 0.64 (CI 0.19 – 2.17) for low WBCs.     
Conclusion: Results suggest there was no statistically significant evidence indicating 
children with chronically low platelets or WBCs were at greater risk for incidences when 
compared to normal values.  In patients with low hemoglobin values there was an 
increased risk for minor events such as tachycardia. This supports our original hypothesis 
that a symptom-based approach in determining appropriateness for PT may be utilized in 
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Introduction: Literature Review 
When deciding whether or not it is safe to work with a patient, a review of lab 
values is performed to rule out any critical values that may caution or contraindicate 
mobilization of a critically ill patient.  According to the guidelines put together by the 
acute care section of the American Physical Therapy Association (APTA) for 
hematological blood values in particular, these values include: normal white blood cell 
(WBC) count 4,500-11,000/mm
3
 in adult males and females, normal platelet count of 
150,000-350,000/microL in adult males and females, and normal hemoglobin (Hgb) 14.4-
16.6 g/dL in adult males and 12.2-14.7 g/dL in adult females.
1
  Within the article that 
outlines these normal values it is suggested that therapists do not proceed with exercise if 
WBC count is less than 5,000/mm
3
 and is accompanied by a fever, if Hgb is less than 8 
g/dL, or if platelets are less than 20,000/microL.
1
 
  These guidelines are ambiguous when it comes to pediatric clients. Pediatric 
values were not specified in any APTA acute care document, however it was noted that 
they will vary from birth to 15 years old.  An online pediatric care resource outlines that 
normal WBC count in children ranges from 5,500-15,500/mm
3
 for those two to five years 
of age, 5,000- 14,500/mm
3
 for those five to eight years, 4,500-13,500/mm
3
 for those nine 
to twelve years of age, and 4,500-13,000/mm
3
 in those 13 to 18 years of age.
2
  Platelets 
should range from 150,000-550,000/mm
3
, and hemoglobin should be within 11.5 to 15.5 
(g/dL).
2
  Children’s Hospitals and Clinics of Minnesota, the site at which this particular 





exception of 13-16 g/dL as normal hemoglobin for males and 12-16 g/dL as normal for 
females in the 13-18 year age range.  Normal platelets for a child of any age at Children’s 
Hospital of Minnesota range from 250,000-450,000/mm.
3
 
Although the guidelines have been in place for many years, evidence for their use 
is lacking.  In fact, no randomized controlled trials were used to establish these normative 
values. The lab value guidelines given for adults were compiled by a task force of the 
Acute Care section of the national APTA.  They used several acute care textbooks for 
physical therapists, guides on the interpretation of laboratory tests and critical lab values, 
and lab value reference books to determine their guidelines.
3 
 Examining statistics 




 notes that “normal” lab values are determined by whether the value falls 
within a normal, bell-shaped curve.  He notes that there are people outside of two 
standard deviations from the mean of a lab value who are still considered healthy 
individuals.  He cautions, along with authors from several other articles, that laboratory 
values should not be examined in isolation.
1,4,5,6,7
  People have died with “normal” lab 
values, and people have lived perfectly normal lives with “abnormal” lab values.  In 
addition lab values considered “abnormal” may be “normal” for a particular patient.  
Irion
5
 states in his article that therapists should “…use good clinical judgment, 
communication with other healthcare providers, and monitor[ing] the responses of 
patients to therapy, rather than follow published guidelines.”   Thus, there is a consensus 











suggests many ways therapists may decide if a patient is safe to be 
mobilized, including objective and subjective factors.  Objective factors include heart rate 
(HR), blood pressure (BP), rate pressure product (RPP), cardiac status, oxygenation, 
respiratory pattern, presence of mechanical ventilation, hemoglobin, platelet count, white 
blood cell count, fever, and blood glucose level.  Subjective considerations include the 
patient’s facial expression, emotional state, level of pain, level of anxiety, pallor, rate of 
perceived exertion (RPE), diaphoresis, and overall physical appearance.  Other factors 
that should be included are whether the patient has any orthopedic precautions, level of 
cognition, incisions, risk or presence of deep vein thrombosis, nutritional status, as well 
as the presence of various lines and tubes. These guidelines in conjunction with clinical 
judgment, reasoning, and experience should help in determining when critically ill 
patients are appropriate for mobilization.
12,13,15
 
There are many physiological reasons behind why we may not mobilize a patient 
with abnormal blood values.  These abnormal blood values are indicative of blood 
disorders in patients with cancer as the result of chemotherapy and the presence of 
tumors.
1
  Disorders include anemia, leukocytosis, leucopoenia, and thrombocytopenia.  
Each of these disorders has different implications for therapy when initiating 
mobilization of the critically ill patient.   
Children with cancer, specifically leukemia or lymphoma (two of the most 





due to the destruction of red blood cells when these diseases cause the immune system to 
produce anti-bodies that clump red blood cells together.  These clumps of red blood cells 
are then recognized by the body as foreign and are destroyed.
8
  These and other pediatric 
cancers also often attack the child’s bone marrow where red blood cells are made and 
replace it with fibrotic tissue, or radiation destroys bone marrow stem cells.
8
  
Chemotherapy drugs also can lower the amount of healthy blood cells, as these drugs are 
cytotoxic and not specific to only the tumor cells.
8
   
Hemoglobin is the predominant oxygen-carrying protein within red blood cells.  
A low red blood cell count due to a change in the quantity or quality of red blood cells 
and thus a decrease in the oxygen carrying capacity of the blood is defined as anemia.
8
  
Therefore, low levels of hemoglobin correspond with a decreased amount of oxygen 
available to the tissues of the body and often result in anemia.   
Exercising a patient with anemia places increased oxygen demands on the body 
and causes the heart rate to increase.  An increase in heart rate can lead to tachycardia, 
with accompanying fatigue, generalized weakness, loss of stamina, and shortness of 
breath.
8
  Tachycardia can lead to dysrhythmias, which rarely but sometimes can lead to 
sudden cardiac arrest.
8
  One study by Unverferth et al. found an increase in cardiac 
dysrhythmias recorded on a Holter monitor for patients with cancer who exerted 
themselves two to six hours following chemotherapy.
9
  This study recommended patients 
undergoing chemotherapy do not exercise within two to six hours following treatment. 
One way to determine whether or not a patient has anemia and the severity of 





g/dL.  Light exercise is permitted if Hgb ranges from 8-10 g/dL, and Hgb >10 allows for 
the patient to attempt resistive exercise according to APTA guidelines.
1
  
Leukocytosis is the presence of high levels of white blood cells (> 11,000/mm
3
), 
indicating likely presence of infection or fever.
1,5,6
  Acute infections and fever often place 
greater oxygen demands on the body, and therefore, it is important to carefully monitor 
oxygen saturation levels, respiratory rate, and rate of perceived exertion during therapy.   
Leucopenia is the result of an abnormally low WBC count (< 5,000/mm
3
), often 
due to the toxic effect chemotherapy drugs have on these cells.  A patient with a low 
white blood cell count may be at an increased risk for infection and fevers, leading to 
increased oxygen demands on the body; thus requiring the same precautions as above.
7,8
  
According to the APTA guidelines, if the WBC count is less than 5,000/mm
3
 and 
accompanied by a fever, exercise is contraindicated.  If WBC count is greater than 
5,000/mm
3




Thrombocytopenia is low platelets (< 150,000/microL) in the blood, indicating an 
increased risk for spontaneous bleeding and decreased ability for the bleeding to clot.   
Platelets are also made in the bone marrow and can be destroyed by chemotherapy and 
radiation.  Patients with very low platelet counts are at high risk for vascular trauma and 
bleeding as a result of activity or significant increases in blood pressure.
12,13 
 Patients with 
this disorder may present with ecchymosis or purpura spots.  According to the APTA 
guidelines, exercise is contraindicated in patients with a platelet count of less than 





of motion is permitted.  If the platelet count is greater than 50,000/microL, resistive 
exercises can be attempted.
1, 7  
 
APTA Exercise Guidelines 
Hemoglobin: 
<8: No exercise permitted 
8-10: Light exercise permitted 
>10: Resistive exercises permitted 
Platelet Count: 
<20,000: No exercise 
20,000-50,000: Light exercises (no PROM, but light AROM is 
permitted) 
>50,000: Resistive exercises permitted 
WBC:   
<5000 with fever: No exercise permitted 
>5000: Light exercise, progress to resistive exercise permitted 
 
Research and data regarding the risks of exercise and mobility for patients with a 
cancer diagnosis suffering from the above blood disorders continue to be lacking.
8
  Some 
physicians recommend abstaining from or minimizing amounts of physical exercise due 
to the increased risk of bleeding and tissue damage in patients with low hemoglobin and 
platelet blood counts. However, according to Stiller et al.
6
 chronically low blood values 
for a particular patient should be treated differently than an acute change.  Chronically 
low blood values may be seen with some kinds of chronic diseases, such as chronic renal 
failure.
7
  If a patient has been living stably with chronically abnormal lab values it has 
been the practice of many physicians to allow physical activity in order to prevent the 
deleterious results of bed rest and inactivity.  These deleterious effects include: muscle 
weakness, decreased muscle endurance, negative nitrogen balance, pneumonia, 





deconditioning, skin breakdown, depression, fatigue, and decreased quality of life.
10
  
Therefore, it is important to weigh the possible risks and benefits of exercising a critically 
ill patient with abnormal blood values.  There is a large body of research that has come 
out in the past two decades which highlights the benefits of exercise for critically ill 
patients, including our area of interest, patients with cancer.  
To date medical professionals continue to debate the possible positive or negative 
effects exercise has on patients diagnosed with cancer.
14 
 As mentioned above, it has been 
theorized that vigorous exercise may be harmful for patients with cancer; however, no 
literature supports this notion. In a review of literature regarding early exercise therapies 
for patients with a cancer diagnosis, 16 of out 18 intervention studies and five out of six 
descriptive studies documented statistically significant results for various quality of life 
outcome measures. Four meta-analyses and two systemic reviews on the effects of 
exercise and aerobic capacity, fatigue, and quality of life in patients with cancer were also 
found.
19
  The meta-analyses and systemic reviews on exercise and patients with cancer 
revealed 12 studies on exercise capacity, 14 on fatigue, and 19 studies regarding the 
physical quality of life. Nine randomized control trials looked at the effects of exercise 
training on muscle strength. A large amount of evidence from these studies supports the 
positive effects of exercise on physiological outcomes during and after cancer 
treatments.
19 
 We were unable to find any studies examining the effects of exercise on 
children with cancer specifically, yet there are many studies of adult cancer populations 






In accordance with the evidence that shows physical activity to have a positive 
impact on function, quality of life, and improving psychosocial well-being in patients 
with cancer undergoing treatment, the studies also revealed that increased physical 
activity after a cancer diagnosis reduces the risk of cancer reoccurrence and mortality.
19
  
The literature has consistently shown that physical exercise following a cancer 
diagnosis improves quality of life.
16
  Many of the physical and functional deficits as a 
result of cancer and its treatment are impacted by therapeutic interventions including 
exercise.
16,19
  The literature also shows that exercise during and/or following cancer 
treatments prevents decline and can improve cardio-respiratory function, body 
composition, immune function, strength and flexibility, body image, self-esteem, and 
mood.  Exercise can also decrease the number and severity of side effects, decreasing 
duration of hospitalization, and improving the likelihood for completion of chemotherapy 
treatment.  Similar to findings by vanWeert et al.
19 
the psychosocial benefits of exercise 
in patients with cancer include better adjustment to illness, reduction of stress, and 
decreased rates of depression and anxiety.
20
 
Fatigue is one of the most common symptoms experienced after high dose 
chemotherapy, occurring in 70-90% of patients with cancer.
11,13 
 Patients describe fatigue 
as one of the most difficult symptoms to deal with during chemotherapy treatments, even 
more distressing than pain, nausea, or vomiting. The fatigue experienced is typically 
thought to be due to cancer related anemia from decreased hemoglobin levels as a result 
of chemotherpay.
11,13 
 As previously mentioned, when a patient is experiencing anemia 





lead to breathlessness, tiredness, and extreme fatigue. Other disadvantages of anemia 
include the need for blood transfusions, diminished energy, lethargy, sexual dysfunction, 
impaired concentration, impaired memory, and a decline in intellectual ability. This can 
lead to decrease in a patient’s quality of life and reduce the motivation and desire to 
participate in exercise.
12   
The National Cancer Institute defines mild anemia as hemoglobin levels of 10-11 
g/dL. Moderate anemia is defined to be hemoglobin levels between 8-9.9 g/dL, and 
severe anemia as 6.5-7.9 g/dL.
11 
 Mild-moderate anemia, although important to note, 
rarely has a negative impact on a patient’s mortality, but has been associated with 
decreased quality of life and functional status.  
As recommended by the APTA,
1
 patients with hemoglobin levels between 8-10 
g/dL are permitted to participate in light exercise. As physical therapists, this is an ideal 
time to help improve the quality of life and function of patients receiving chemotherapy 
and experiencing anemia. Evidence has shown that sedentary patients with breast cancer 
who have a reduced exercise tolerance report higher degrees of fatigue during 
chemotherapy treatments when compared to more active, physically fit patients.
13
  
Exercise offers the strongest evidence for relieving cancer related fatigue.
2 
 There 
have been 11 published reports by four different research groups testing the impact 
exercise has on fatigue during high dose chemotherapy. Two additional studies have 
looked at the effects of exercise on patients after treatment has been completed. All 13 
studies indicate significantly lower levels of fatigue in patients who exercised compared 
to sedentary controls.
13 





cancer to have lower resting heart rates, lower blood pressure, more energy, increased 
muscle strength, and improved restful sleep.  Many patients undergoing high dose 
chemotherapy experience feelings of depression, stress, and anxiety.
20 
 Using exercise as 
part of rehab can help improve some of the negative psychosocial aspects often 
accompanying a cancer diagnosis.  Although the benefits of exercise in patients with 
cancer related fatigue have been shown to be consistent across studies, the studies are 




The research shows that exercise can improve function, quality of life, and 
decrease fatigue in individuals with a cancer diagnosis. Exercise has also been found to 
be safe and improve function in patients with cancer who are critically ill with low blood 
count values.  
Current research regarding decisions on when to mobilize patients in the intensive 
care unit (ICU) is limited. Mobility interventions for patients in the ICU have not 
received much attention. Despite the knowledge that exercise is beneficial for decreasing 
the effects of immobility, and that exercise helps patients return to previous level of 
functioning, the exact manner and guidelines regarding when to administer rehab 
treatment or safely administer mobility maneuvers to critically ill patients is not well 
understood.
6
  Research shows improvement in mood, coordination, muscle strength, 
balance, and work tolerance when critically ill patients receive mobility therapy.
6
  Several 
publications have shown a benefit to early exercise therapies for inpatient populations.
18
  





weight changes, autonomic function, subsequent hospitalization costs, and cardiovascular 
morbidity and mortality.
25,19
  Inpatients receiving early rehab therapy reported a greater 
than 50% reduction in depressive symptoms, and also demonstrated better function in 
activities of daily living (ADLs) after only one month. 
 
Other existing views advise that exercise should only be initiated at the point of 
complete remission from cancer.
17
  Although valuable to acknowledge prevailing advice 
for patients to rest and avoid intense exercise, this should not outweigh the risks of 
deconditioning and immobilization. A pilot study by Baker et al.
18
 showed that 31 
critically ill patients who took part in 69 rehab sessions were mobilized without any 
deterioration in their health status. Patients were deemed suitable for therapy based on 
guidelines set by Stiller et al.
6
 These guidelines for mobilizing critically ill patients 
recommend that hemoglobin values be stable and >7g/dL, platelet counts stable and 
>20,000/microL and white blood cell counts between 4,300-10,800/mm
3
.  If any blood 
value is not within these guidelines, appropriateness of mobilization should be discussed 
with another physical therapist or other medical professionals before deferment.
7,22
   
Few research studies measure blood values during exercise interventions for 
patients with cancer. The research is even more limited when looking at studies that 
exercised patients with very low blood counts. We did not find any study that exercised 
patients with hemoglobin, platelets, or white blood cell counts much below recommended 
guidelines as set by the APTA. A study by Elter et al.
17
 looked at the effects of aerobic 
training on patients with a cancer diagnosis undergoing high dose chemotherapy. The 





sub-maximal intensity. The researchers monitored blood values and set guidelines as for 
when to discontinue treatment. When patients’ platelets were >20,000/microL without 
any sign of bleeding, they were allowed to proceed with the program but were under 
special precautions that blood pressure not exceed 170/100. Patients’ whose platelets 
reached <10,000/microL or hemoglobin levels <8g/dL necessitated a blood or platelet 
transfusion prior to continuation of aerobic training. By the end of the study, all trained 
subjects performed better on the final test. Sub-maximal endurance capacity also showed 
significant improvements for the training group during the period of hospitalization. 
Throughout the study, median platelet count was 27,000/microL with a minimal count of 
8,000/microL.  Hemoglobin values on average were 9.2g/dL with minimal blood values 
reaching 7.7g/dL.  
Patients participating in aerobic exercise training were found to be more likely to 
complete the full intended number of chemotherapeutic treatments as compared to 
untrained patients.
17
  The researchers in this study did not use previously set blood value 
guidelines for the continuation of physical activity. Instead they only judged patients’ 
ability to participate in exercise based on clinical signs of bleeding.  None of the patients 
in the study with platelet counts <10,000/microL or hemoglobin values <8g/dL suffered 
bleeding or adverse reactions to exercise.  Patients with severe active infection were not 
allowed to participate in exercise training. This study illustrated the positive effects 
exercise has on patients with cancer undergoing high dose chemotherapy.  It also showed 










 looked at the effects of an interval training program on patients 
with cancer receiving high dose chemotherapy.  Sixteen patients participated in a rehab 
program for six weeks and another 16 patients served as controls. Exercise treatments 
were held for 15-30 minutes at an intensity of approximately 80% of heart rate 
maximum. Physical function, cardiac function, and hemoglobin concentrations were 
measured at the time of discharge from the hospital and then again seven weeks later 
after the training intervention.  At baseline, hemoglobin levels were 10±1.4g/dL for the 
training group and 10±1.2g/dL for the control group.  After seven weeks, hemoglobin 
concentration was significantly higher in the training group, 13±1.0g/dL versus 
12±1.4g/dL for the control group. There were no cardiac, infectious, or bleeding 
complications seen throughout the training program. To reduce the risk of bleeding or 
infections in the training group, patients in this study were not allowed to start training 




.  No 
adverse reactions were noted for any of the patients in the training group. Anemia was 
not a contraindication for inclusion in the training program.  The researchers felt it was 
important to allow patients with anemia to participate in training due to the positive 
effects exercise has been shown to have on improving physical performance and 
hemoglobin levels in patients with cancer.  Many patients with cancer suffer from anemia 
so defining this condition as a contraindication for the exercise program would exclude 
many patients from rehab at a time when they might benefit from it most.
21 
 The exercise 





stem cell transplantation, and the effect the aerobic training program would have had on 
the patients without stem cell transplantation remains unknown. 
A study by Dimeo et al.
14
 looked at the effects of aerobic exercise on patients with 
cancer. The treatment group took part in daily aerobic exercise programs consisting of 
biking with a bed ergometer for one minute at an intensity level of at least 50% of cardiac 
reserve. This was repeated 15 times with one minute breaks between exercise bouts for a 
total of 30 minutes each day. Patients with a fever >37.5 degrees Celsius or platelets 
<10x10
9
/L were instructed to discontinue training until their fevers went away.  
Individuals who continued to have severe infections or multiple complications were not 
allowed to resume training. Patients were transfused when hemoglobin blood counts were 
<8g/dL or when platelets were <20X10
9
/L. This study found the training group to have 
shorter duration of neutropenia 6.6±1.5 days versus the control group 7.6±1.6 days. The 
training group also required less platelet transfusions and was found to have shorter 
duration of thrombopenia (platelets <50x10
9
/L) 10.9±3 days versus the control group 
12.4±3.7 days. There were no complications in the patients who participated in rehab 
immediately after completing high dose chemotherapy. The aerobic exercise improved 
physical performance and reduced fatigue in patients. The researchers concluded that the 
severe loss of function often observed after high dose chemotherapy can be partially 
prevented with rehab exercises.  
Stiller et al.
22
 also looked at the effects of mobilizing critically ill patients with 
low blood values.  Patients’ baseline hemoglobin concentration had a mean value of 





301,000/microL with a range of 42,000-742,000/microL.  White blood cell counts ranged 
from 4,400-20,100/mm
3 
with a mean baseline value of 10,500/mm
3
.  In two of 69 
sessions for mobilization, patients reported feeling dizzy but did not require any direct 
medical intervention, nor did it limit the treatment session.  No change in the severity or 
frequency of cardiac arrhythmias was noted during mobilizations.
22
 In three of 69 
occasions, a deterioration in patients’ condition required intervention.  All three 
occasions were due to a fall in SpO2.  Although there was a low incidence of problems 
during the treatment mobilizations a comprehensive screening process was used to select 
appropriate patients for mobilization. The guidelines set by Stiller et al.
13
 were used as 
parameters for mobilization. These included hemoglobin values stable and >7g/dL, 
platelet counts stable and >20,000/microL and white blood cell counts between 4,300-
10,800/mm
3
.  The low incidence of adverse reactions in this study suggests that 
guidelines by Stiller et al.
13
 and utilizing clinical judgment to assist in deciding 
appropriateness of critically ill patients for mobilization is safe.  
In another study, 20 patients with cancer undergoing bone marrow transplantation 
participated in a rehab program. The program consisted of treadmill walking according to 
an interval training protocol for six weeks.  Each treatment session was approximately 30 
minutes at an intensity 80% of heart rate maximum.
23
 Inclusion criteria for the study 
included sustained platelet counts >20,000/microL, absolute neutrophil count of 1x10
9
, 
and stable clinical condition. Throughout the six week training program, physical 
performance improved and no cardiac, infectious, or bleeding adverse reactions occurred. 





all basic activities of daily living. Other studies have reported impaired physical 
functioning by patients participating in training programs after receiving bone marrow 
transplantation. No such evidence of this was found in this study, and instead, Dimeo et 
al.
23
 observed patients gaining self-confidence, improved physical functioning, and 
improved mood, resulting in higher levels of independence and improved quality of life.  
No evidence currently exists on the safety of exercise for pediatric patients with 
chronically low blood values due to cancer treatment.  However, given the evidence that 
exercise may be appropriate for these patients, we decided to examine the safety of 
physical therapy treatment to see if any critical incidents occur when children with low 
blood values exercise versus children with normal lab values. Specifically, we looked at 
hemoglobin, white blood cell count, and platelet count in relation to critical events for a 
population of children receiving physical therapy at one site where the current practice is 
to set exercise parameters based on the symptom assessments of the attending physical 
therapists and not on the blood values guidelines.  This situation gives us the unique 
ability to look at the safety of exercise in patients who may have chronically low blood 
values but are clinically stable.   
 
Chapter II  
Methods 
 
For this study a retrospective chart review was performed.  The subjects were a 
sample of 73 consecutive children diagnosed with a non-CNS cancer.  The children 
ranged in age from 3 to 18 years and had received physical therapy while undergoing 





met the inclusion criteria and did not meet the exclusion criteria were selected 
consecutively by the lead researcher from the Children’s Hospitals and Clinics of 
Minnesota pediatric oncology database. The inclusion criteria for subjects included a 
current diagnosis of a non-CNS cancer, a chemotherapy treatment time greater than or 
equal to two months (to ensure likelihood of chronic low blood values), were between 3 
and 18 years of age, and had at least two sessions of physical therapy from Children 
Hospitals and Clinics of Minnesota.  Subjects were excluded if they did not meet the 
inclusion criteria, had a previously diagnosed cardiac disorder, or if they had undergone a 
recent surgical resection. 
  For each subject, up to four physical therapy (PT) visits were identified in the 
electronic medical record and examined until 201 chart reviews were completed.  Only 
physical therapy visits within 24 hours of a complete blood count were reviewed.  The 
patient’s hemoglobin, platelets, and white blood cell values were recorded once a 
qualifying (within 24 hours of a CBC) PT visit was identified, along with the type of 
interventions performed, the patient’s subjective symptoms, and any modifications made 
by the therapist during treatment. The electronic medical record was then examined for 
two days following the PT visit for any critical incidents that may have occurred.  The 
areas of the chart reviewed included hematology/oncology notes, nursing notes, and 
emergency department notes.  Critical incidents were defined as: syncope, cardiac 
arrhythmia, low blood pressure, oxygen saturation <90%, shortness of breath, 
bradycardia, tachycardia (based on age-adjusted normal values), falls, pain, impaired skin 







Once the data was gathered, a Chi-square analysis was used to look for a 
correlation between critical incidents and chronically low hemoglobin, platelets, and 
white blood cells.  For cases where Chi-square cells were <5, a Fisher exact test of 
significance was used.  Risk ratio was also calculated in order to determine the relative 
risk of a critical incident following physical therapy intervention when subjects’ blood 
values were low as compared to subjects with normal blood values. 
The retrospective chart review included 201 physical therapy treatment sessions 
for a total of 73 patients.  No more than four physical therapy sessions per child were 
analyzed with a mean number of 2.8 visits per child.  The mean age was 9.5 years old and 
ranged from 3-18 years. The three most common cancer diagnoses were leukemia (60%), 
solid tumors (32%), and lymphoma (8%).  Forty-five percent of the subjects were male 
and 55% were female. Approximately 14% of the subjects had had either a red blood cell 
or platelet transfusion in the past week. Fifteen percent of the patients were being seen for 
inpatient physical therapy, whereas 85.5% were seen in an outpatient setting.  
The mean blood values for hemoglobin, platelets, and white blood cells taken 
within 24 hours of a patient’s physical therapy treatment session were found (Table 1).  
The mean hemoglobin for this patient population was found to be 10.5 g/dL. The mean 
platelet value was 226.6 x10
3










Hospitals and Clinics of Minnesota, the percentages of subjects whose values were 







Abnormal hemoglobin and platelet values were divided further according to 
APTA guidelines for exercise. Ten percent of the patients had hemoglobin values of <8 
and 5.5% of the subjects had platelet values <20,000 indicating no exercise permitted. It 
is important to note the low percentages of patients with normal blood values and the 
very high percentages of patients with abnormal blood values in this pediatric oncology 
population.  More than two thirds of the pediatric oncology population receiving physical 
therapy at Children’s Hospitals and Clinics of Minnesota had abnormal blood values. 
Very few patients had such low blood values that no exercise would have been 
recommended by the APTA guidelines.  
Of the 201 patient charts reviewed, there were a total of thirteen critical incidents 
that occurred within two days following a physical therapy treatment session. 
Table 1.  
Mean blood values for the examined pediatric oncology population and 





Approximately 6.5% of the patient population actually had a critical incident, as defined 
by the research study. The thirteen events included seven events of tachycardia, three 
subjective complaints of pain, two fevers, and one fall that occurred during the physical 
therapy session. There were no episodes of arrhythmia, syncope, hypotension, oxygen de-
saturation less than 90%, shortness of breath, major bleeds, or skin integrity issues. 
Having a critical incident was very rare, and those that did occur were not severe enough 
to institute major medical attention. Seventy-six percent had no documented adverse 
symptoms during their physical therapy session.  The remaining 24% had complaints of 
fatigue, pain, nausea, and/or shortness of breath.  Physical therapy was modified 
accordingly in 5.5% of patient cases. These symptoms were not defined as critical 
incidents.   
There was very little difference in the percentages of patients experiencing critical 
events when blood values were normal as compared to abnormal blood values (Figure 1). 
For example, 3% of patients with normal platelet values had a critical event, whereas 4% 
of patients with abnormal platelet values had an event. There was only a 6% difference in 
critical events between subjects with normal hemoglobin values and abnormal values. A 
Fisher’s exact test showed no significant relationship between low hemoglobin, low 
platelets, or low white blood cells and the number of critical incidents. Chi-Square was 
2.56 (p= 0.196), 0.198 (p=0.776), and 0.501 (p=0.444) for low hemoglobin, low platelets, 









          The risk ratio for low hemoglobin was 4.3 (CI= 0.58-32.20) (Figure 2). For low 
platelets the risk ratio was 0.79 (CI= 0.29-2.20). The risk ratio for low white blood cell 
count was 0.64 (CI= 0.19-2.17).  All confidence intervals include one, and therefore 
demonstrate there may not be an increased risk of critical event when blood values are 




Distribution of Critical Events in Patients with Normal versus 
Abnormal Blood Values 
Figure 2. 
 Risk Ratios of Critical Incidents in Patients with Low Blood Values 





             The distribution of critical incidents for normal and abnormal hemoglobin values 
was also analyzed (Figure 3).  For patients whose hemoglobin values were within normal 
age adjusted ranges, 2% had a critical event. For patients with an abnormal hemoglobin 
value yet >10, 8% of subjects had a critical event. For hemoglobin values 8-10, 6.5% had 
a critical event. For hemoglobin <8, indicating no exercise permitted, 20% had a critical 
event. No significant differences were found in the way confidence intervals were 
distributed for platelets (X
2
=5.795, p= 0.122). A power analysis indicated insufficient 






Figure 3.  






The distribution of critical events for normal and abnormal platelet values found 
that 8% of patients whose platelets were normal had a critical event (Figure 4). For 
patients with abnormal platelets, yet >50,000, 7% had a critical event. For values 20,000-
50,000, zero out of the four participants had a critical event. For patients with platelets 
<20,000, indicating no exercise permitted, zero of the seven had a critical event. No 
significant differences were found in the way confidence intervals were distributed for 
platelets (X
2







For patients with low platelet blood values, it is recommended that physical 
therapy avoid activities such as stretching due to the decreased ability of the patient’s 
blood to clot. When patients’ platelet values were abnormally low, there was no 
significant difference found in the distribution of critical incidents in patients with 
Figure 4.  






stretching versus no stretching (X
2
=0.769, p= 0.476) (Table 2). Four percent of patients 
with abnormal platelets and were stretched had a critical event, whereas 8% of patients 
without stretching during physical therapy had a critical event.  Another common concern 
is for patients with low hemoglobin values performing endurance exercises.  It is 
recommended that physical therapy avoid endurance exercises when patients’ 
hemoglobin values are abnormally low due to increased risk of fatigue, tachycardia, and 
the increased oxygen demands placed on the body’s tissues. There was no significant 
difference found in the distribution of critical incidents in patients with abnormally low 
hemoglobin when endurance exercises were done versus no endurance exercises 
(X
2
=0.066, p= 1.00) (Table 3).  Eight percent of patients with abnormal hemoglobin 
values who performed endurance exercises had a critical event, whereas 9% of patients 








Table 2.  
Patients with abnormal platelet values.  Distribution of 
critical events when stretching versus no stretching was done 
during PT. 
Table 3.  
Patients with abnormal hemoglobin values. Distribution of critical 
events when endurance exercises versus no endurance exercises 





The correlation between certain sub-groups of patients and critical incidents was 
also analyzed. There were no relationships found between critical incidents and type of 
cancer (X
2
=1.87, p=0.39) or age (X
2
=0.104, p=0.75) of the patient. The correlation 
between the types of physical therapy exercise performed was also analyzed for 
relationship with critical events. There were no statistically significant relationships 
(p<0.05) found between critical incidents and interventions tested. Interventions included 
strength training with resistance (X
2
=0.686, p=0.404), strength training with jumping 
(X
2
=2.093, p=0.247), gait training (X
2












Chi-Square analyses indicated no significant correlation between critical incidents 
and chronically low hemoglobin, low platelets, or low white blood cells. High 
percentages of patients in the pediatric oncology population have chronically low blood 
values.  According to Stiller et al.
6
 chronically low blood values for a particular patient 
should be treated differently than an acute change.  If a patient has been living stably with 
chronically abnormal lab values it has been the practice of many physicians to allow 
physical activity in order to prevent the deleterious results of bed rest and inactivity.  
These deleterious effects include: muscle weakness, decreased muscle endurance, 
negative nitrogen balance, pneumonia, thrombosis, kidney stones, increased diuresis, 
orthostatic hypotension, cardiovascular deconditioning, skin breakdown, depression, 
fatigue, and decreased quality of life.
10





risks and benefits of exercising a patient with abnormal blood values.   In the current 
study, physical therapy was found to be very safe when using symptom based guidelines 
for activity in children being treated for cancer with a very low percentage of critical 
events.  
Of the thirteen critical incidents that did occur, all events were minor with 
approximately 50% having symptoms of tachycardia. Tachycardia happens to be a 
common symptom of low hemoglobin, and its occurrence is somewhat expected and does 
not merit discontinuing physical therapy. No major events such as heart arrhythmias, 
syncope, hypotension, or major bleeds occurred in any of the patients receiving physical 
therapy treatment.  
There was also no increased risk of critical events in children with low platelets or 
low white blood cells when compared to normal blood values with risk ratios 0.79 and 
0.64 respectively.  An increased risk ratio of 4.3 was noted for critical incidents in 
subjects with low hemoglobin as compared to normal hemoglobin values. Despite an 
increased risk ratio, a confidence interval of 0.58-32.30 indicates patients had a decreased 
risk of event, no additional risk, or an increased risk of critical event. We cannot be 
confident that the risk ratio for hemoglobin is significant. A power analysis for 
hemoglobin indicated insufficient number of subjects to be confident in the finding of no 
relationship.   
A study by Dimeo et al.
14 
found similar results when looking at the effects of 
aerobic exercise on adult patients with cancer.  The treatment group took part in daily 





intensity level of at least 50% of cardiac reserve.  This was repeated fifteen times with 
one minute breaks between exercise bouts for a total of 30 minutes each day.  There were 
no complications in the condition of patients who participated in rehab immediately after 
completing high dose chemotherapy. The aerobic exercise improved physical 
performance and reduced fatigue in patients. The researchers concluded that the severe 
loss of function often observed after high dose chemotherapy can be partially prevented 
with rehab exercises.  
Stiller et al.
22
 looked at the effects of mobilizing ill patients with low blood 
values.  Patients’ baseline mean hemoglobin values were 9.1 g/dL and ranged from 7-
15.8g/dL.  Baseline platelet values had a mean value of 301,000/microL and ranged from 
42,000-742,000/microL.  During 2 of 69 mobilization sessions, patients reported feeling 
dizzy but did not require any direct medical intervention.  In 3 of 69 occasions, a 
deterioration in patients’ condition required intervention.  All three occasions were due to 




In an additional study by Dimeo et al.
23
 patients with cancer undergoing bone 
marrow transplantation participated in a rehab program. The program consisted of 
treadmill walking according to an interval training protocol for six weeks.   Throughout 
the six week training program, physical performance improved and no cardiac, infectious, 
or bleeding adverse reactions occurred.  No such evidence of impaired physical 





functioning, and had less depressive moods resulting in higher levels of independence 
and improved quality of life.  
In the current study, there was also no significant relationship between critical 
incidents and specific sub-populations of patients such as type of cancer, age, or type of 
physical therapy exercise.  When patients’ platelet values were abnormally low, there was 
no significant difference found in the distribution of critical incidents in patients with 
stretching versus no stretching.  There was no significant difference found in the 
distribution of critical incidents in patients with abnormally low hemoglobin when 
endurance exercises were done versus no endurance exercises.   
These results of the current study suggest the use of a symptom-based approach in 
determining appropriateness for physical therapy may be utilized in pediatric populations 
experiencing chronically low blood values.  An additional screening process for 
determining patients appropriate for physical therapy has been proposed by Stiller et. al.
13
  
The guidelines recommend that hemoglobin values be stable and >7g/dL, platelet counts 
stable and >20,000/microL and white blood cell counts between 4,300-10,800/mm
3
.  If 
any blood value is not within these guidelines, appropriateness of mobilization should be 
discussed with another physical therapist or medical professional before deferment.  
Therapists may be able to decide if a patient is safe for physical therapy based on 
additional objective and/or subjective factors.  Objective factors include heart rate, blood 
pressure, cardiac status, oxygenation, respiratory pattern, or blood glucose levels.  
Subjective symptoms such as the patient’s facial expression, emotional state, pain, 





determining patients’ appropriateness for physical activity.  These guidelines in 
conjunction with clinical judgment, experience, and current APTA hematological 
guidelines may be utilized in populations experiencing chronically low blood values.  
Limitations of this study include the small sample size.  Of the 201 total charts 
reviewed, there were only 13 critical incidents identified.  Having so few critical 
incidents makes it difficult to find statistically significant correlations.  Only 9.8% of the 
patients receiving physical therapy had hemoglobin values <8 and only 5.5% of patients 
had platelets <20,000.  Conducting a larger study with more participants may result in 
more subjects with extreme low blood values allowing researchers to investigate the 
relationship between physical therapy and critical incidents.  Also, if we are suggesting a 
symptom-based approach to determining level of activity during physical therapy, it 
would be interesting to note the types of modifications physical therapists made to 
treatment sessions when patients’ blood values were low.  Although efforts were made to 
record any changes to physical therapy treatment sessions, all modifications may not 
have been fully documented limiting our ability to know what specific changes actually 
minimized the occurrence of critical events.  In addition, it is possible we may not have 
had access to all emergency medical files from outside hospitals.  Although one can 
expect a phone call would be made from the outside hospital and placed in the child’s 
medical record, we cannot be completely confident we were able to record all critical 











The results of this study support our original hypothesis.  There was no difference 
in the amount of critical incidents occurring within two days after physical therapy in 
pediatric oncology patients with chronically low blood values versus normal blood 
values.  Physical therapy was found  to be safe for children experiencing chronically low 
blood values from chemotherapy treatment when the therapist used symptoms as a 
guideline for treatment parameters.  Additionally, when analyzed, there were no sub-
populations of patients found to be at an increased risk of critical events.  The evidence 
suggests a symptom-based approach in determining appropriateness for physical therapy 
may be utilized in populations experiencing chronically low blood values.  Future studies 
with larger samples sizes are needed to ascertain whether these findings are consistent 


























Patient ID:     PT Treatment Date:  
Age:     Gender: M / F 
Type of cancer:     Time in Oncology Treatment:                          (months) 
Transfusions in last week:  _____RBC _____Platelets 
Physical Therapy seen as:  _____ Inpatient   _____ Outpatient 
Lab Values Date and Time: __________ 




Physical Therapy Interventions: 
_____ Strength Training, if yes  Resistance given Yes / No    circle type: weights, bands, manual 
_____ Gait Training       Pilates, jumping, closed chain 
_____ Endurance Exercise, if yes   Running Yes / No 
_____ Balance Training 
_____ Stretching, if yes  Joint Mobilization Yes / No 
_____ Other:    
 
PT recorded modified due to symptoms:  ____ Yes    ____ No 
Symptoms noted by PT: 
 _____ Paleness   _____Fatigue   _____ Headache  
_____ Shortness of breath   _____ Increased HR  _____ Lethargy 
_____ Bruising   _____Bleeding of gums reported 
_____ Parent reporting change in behavior 
_____ Other: _________________ 
_____ Other: _________________ 
 





w/in 2 hours after PT 
Critical Incidences 1 
day after PT 
Critical 
Incidences 2 days 
after PT 
Syncope  Yes / No Yes / No Yes / No Yes / No 
Cardiac arrhythmia Yes / No Yes / No Yes / No Yes / No 
Low blood pressure Yes / No   BP: Yes / No   BP: Yes / No   BP: Yes / No   BP: 
SpO2 <90% Yes / No Yes / No Yes / No Yes / No 
Shortness of Breath Yes / No Yes / No Yes / No Yes / No 
Heart Rate at rest: 
Bradycardia  
Tachycardia 
(use age app. Values)  
Normal 
Brady / Tachy 
Normal 
Brady / Tachy 
Normal 
Brady / Tachy 
Normal 
Brady / Tachy 
Falls Yes / No                                   Yes / No                                   Yes / No                                   Yes / No                                   
  Description of fall: Description of fall: Description of fall: Description of fall: 
Pain Rating 0-10         
Skin integrity (ecchymosis, 
breakdown, erythema) 
        
Fever 
Yes / No   
Temp: 
Yes / No  
Temp: 
Yes / No   
Temp: 
Yes / No   
Temp: 
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